CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-20 | Lanfear Dennis M President & CEO | Grant or award | +86,250 | 654,853 | ||
| 2023-01-20 | McMichael Bryan J See Remarks | Grant or award | +12,500 | 26,386 | ||
| 2023-01-20 | Vexler Vladimir Chief Scientific Officer | Grant or award | +40,000 | 131,323 | ||
| 2023-01-20 | Stilwell McDavid Chief Financial Officer | Grant or award | +40,000 | 104,243 | ||
| 2023-01-11 | Vexler Vladimir Chief Scientific Officer | Shares withheld for taxes | −3,602 | $10.26 | $37K | 91,323 |
| 2023-01-10 | Vexler Vladimir Chief Scientific Officer | Shares withheld for taxes | −3,602 | $9.85 | $35K | 94,925 |
| 2023-01-07 | McMichael Bryan J See Remarks | Shares withheld for taxes | −1,699 | $9.58 | $16K | 13,886 |
| 2023-01-05 | Lanfear Dennis M President & CEO | Grant or award · Stock Option (Right to Buy) | +402,500 | 402,500 | ||
| 2023-01-04 | Lanfear Dennis M President & CEO | Shares withheld for taxes | −10,905 | $9.87 | $108K | 568,603 |
| 2023-01-04 | McMichael Bryan J See Remarks | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-01-04 | Vexler Vladimir Chief Scientific Officer | Shares withheld for taxes | −5,437 | $9.87 | $54K | 98,527 |
| 2023-01-04 | Vexler Vladimir Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2023-01-04 | Stilwell McDavid Chief Financial Officer | Shares withheld for taxes | −5,437 | $9.87 | $54K | 64,243 |
| 2023-01-04 | Stilwell McDavid Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2022-12-30 | Lanfear Dennis M President & CEO | Gift | −4,000 | 432,684 | ||
| 2022-09-07 | McMichael Bryan J See Remarks | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2022-05-18 | O'Donnell-Tormey Jill Director | Grant or award · Stock Option (Right to Buy) | +54,000 | 54,000 | ||
| 2022-05-04 | Newton Charles W. Director | Grant or award · Stock Option (Right to Buy) | +54,000 | 54,000 | ||
| 2022-04-01 | Stilwell McDavid Chief Financial Officer | Shares withheld for taxes | −3,458 | $12.85 | $44K | 69,680 |
| 2022-04-01 | Vexler Vladimir Chief Scientific Officer | Shares withheld for taxes | −3,458 | $12.85 | $44K | 103,963 |
Page 7 of 39 · 768 trades